PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Nephrology, University of Heidelberg, Heidelberg, Germany.\', \'Department of Infectious Diseases, Molecular Virology, University of Heidelberg, Heidelberg, Germany.\', \'Department of Virology, University of Heidelberg, Heidelberg, Germany.\', \'Institute of Immunology, University of Heidelberg, Heidelberg, Germany.\', \'Transplant Immunology Research Center of Excellence, Koç University Hospital, Istanbul, Turkey.\', \'German Center for Infection Research, Partner Site Heidelberg, Heidelberg, Germany.\', \'Division Virus-Associated Carcinogenesis, German Cancer Research Center, Heidelberg, Germany.\', \'Department of Molecular Medicine Partnership Unit Heidelberg, European Molecular Biology Laboratory, Heidelberg, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2022.840136
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 35309320
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Neutralizing Antibody Activity Against the B.1.617.2 (delta) Variant Before and After a Third BNT162b2 Vaccine Dose in Hemodialysis Patients.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35309320>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35309320>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all